We are live on ! Find out more
BNP Paribas Financial Markets

BNP Paribas Financial Markets Portfolio holdings

AUM $206B
1-Year Est. Return 31.61%
 

BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.

This Fund
S&P 500
This Quarter Est. Return
+1.86%
1 Year Est. Return
+31.61%
3 Year Est. Return
+91.73%
5 Year Est. Return
+103.23%
10 Year Est. Return
+394.96%
AUM
$106B
AUM Growth
-$22.4B
Cap. Flow
+$44.2B
Cap. Flow %
41.6%
Top 10 Hldgs %
42.41%
Holding
4,108
New
765
Increased
1,315
Reduced
1,298
Closed
285

Top Sells

Rank Stock Value
1
GILD icon
Gilead Sciences
GILD
+$3.85B
2
EQIX icon
Equinix
EQIX
+$2.31B
3
TSLA icon
Tesla
TSLA
+$2.3B
4
SNDK
SANDISK CORP
SNDK
+$1.87B
5
TRLA
TRULIA INC (DEL)
TRLA
+$1.64B

Sector Composition

Rank Sector Weight
1 Technology 4.77%
2 Financials 3.07%
3 Industrials 1.75%
4 Healthcare 1.67%
5 Materials 1.5%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PHIIK
3151
DELISTED
PHI, Inc. Non-Voting Common Stock
PHIIK
$1.6K ﹤0.01%
+36
New +$1.58K
AVEO
3152
DELISTED
AVEO Pharmaceuticals, Inc.
AVEO
$1.6K ﹤0.01%
88
+14
+19% +$182
ICEL
3153
DELISTED
CELLULAR DYNAMICS INTL INC COM STK (WI)
ICEL
$1.6K ﹤0.01%
+110
New +$1.39K
PMC
3154
DELISTED
PharMerica Corporation
PMC
$1.6K ﹤0.01%
+56
New +$1.56K
BKYF
3155
DELISTED
BK KY FINL CORP
BKYF
$1.6K ﹤0.01%
+46
New +$1.6K
ARC
3156
DELISTED
ARC Document Solutions, Inc.
ARC
$1.6K ﹤0.01%
+273
New +$1.73K
CSG
3157
DELISTED
CHAMBERS STR PPTYS COM
CSG
$1.59K ﹤0.01%
198
+128
+183% +$1.01K
ECPG icon
3158
Encore Capital Group
ECPG
$1.98B
$1.59K ﹤0.01%
35
-93
-73% -$4.11K
KPTI icon
3159
Karyopharm Therapeutics
KPTI
$47.6M
$1.58K ﹤0.01%
2
INTX
3160
DELISTED
Intersections, Inc.
INTX
$1.57K ﹤0.01%
320
-134
-30% -$669
MSL
3161
DELISTED
Midsouth Bancorp, Inc.
MSL
$1.57K ﹤0.01%
+79
New +$1.42K
ESSA
3162
DELISTED
ESSA Bancorp
ESSA
$1.57K ﹤0.01%
+141
New +$1.5K
PLOW icon
3163
Douglas Dynamics
PLOW
$979M
$1.57K ﹤0.01%
89
-166
-65% -$2.88K
ISLE
3164
DELISTED
Isle of Capri Casinos Inc
ISLE
$1.57K ﹤0.01%
+183
New +$1.29K
AEIS icon
3165
Advanced Energy
AEIS
$13.1B
$1.56K ﹤0.01%
+81
New +$1.66K
FTEK icon
3166
Fuel Tech
FTEK
$43.7M
$1.56K ﹤0.01%
276
KS
3167
DELISTED
KapStone Paper and Pack Corp.
KS
$1.56K ﹤0.01%
+47
New +$1.33K
LAYN
3168
DELISTED
Layne Christensen Co
LAYN
$1.56K ﹤0.01%
+117
New +$1.84K
CCOI icon
3169
Cogent Communications
CCOI
$554M
$1.55K ﹤0.01%
+45
New +$1.59K
PSEM
3170
DELISTED
PERICOM SEMICONDUCTOR CP
PSEM
$1.55K ﹤0.01%
+172
New +$1.44K
PERF
3171
DELISTED
Perfumania Holdings, Inc.
PERF
$1.55K ﹤0.01%
229
ASMB icon
3172
Assembly Biosciences
ASMB
$540M
$1.55K ﹤0.01%
20
RTK
3173
DELISTED
Rentech, Inc.
RTK
$1.55K ﹤0.01%
60
-392
-87% -$8.73K
ZAGG
3174
DELISTED
ZAGG Inc Common Stock (Delaware)
ZAGG
$1.55K ﹤0.01%
285
+218
+325% +$1.01K
AX icon
3175
Axos Financial
AX
$5.68B
$1.54K ﹤0.01%
84
+20
+31% +$394

Similar funds

BNP Paribas Financial Markets's Q2 2014 Portfolio in Review

As of Q2 2014, BNP Paribas Financial Markets held 4,108 positions worth $106B, down 17% from $129B the previous quarter. Its ten largest holdings account for 42% of the portfolio.

BNP Paribas Financial Markets deployed $44.2B of net new capital in Q2 2014, opening 765 new positions and adding to 1,315 existing holdings. Its largest new stake was Canadian Pacific Kansas City: 15,162,685 shares worth $560M.

By sector, the portfolio is most concentrated in Technology at 4.8% of assets, down from 25% a quarter earlier, followed by Financials and Industrials.

On the sell side, the largest reduction was Gilead Sciences, an estimated $3.85B trimmed.

  • BNP Paribas Financial Markets's largest Q2 2014 buy was Canadian Pacific Kansas City: 15,162,685 shares worth $560M.
  • BNP Paribas Financial Markets added most to Potash Corp Of Saskatchewan in Q2 2014, an estimated $716M increase.
  • BNP Paribas Financial Markets's biggest Q2 2014 reduction was Gilead Sciences, cutting an estimated $3.85B.
  • BNP Paribas Financial Markets fully exited Walter Investment Mgt Corp in Q2 2014, selling an estimated $477M.
  • BNP Paribas Financial Markets's ten largest holdings make up 42% of its $106B portfolio in Q2 2014.
  • BNP Paribas Financial Markets opened 765 new positions and closed 285 in Q2 2014.
  • BNP Paribas Financial Markets's portfolio value fell 17% quarter-over-quarter to $106B.

Based on BNP Paribas Financial Markets's 13F filing for Q2 2014, filed 14 Aug 2014.